InvestorsHub Logo
Followers 65
Posts 23946
Boards Moderated 0
Alias Born 11/23/2016

Re: Investor2014 post# 338751

Sunday, 12/05/2021 4:51:49 AM

Sunday, December 05, 2021 4:51:49 AM

Post# of 462945
PS! See Sumplementary Information (Stable4.pdf) to the peer reviewed paper. In LME model output for Change in ADCS-ADL outcome, the P-value (F test) for Donepezil was 0,959. So far from stat sig and therefore no notable influence.

Stable 4c
Patient descriptor
P-value (F test)
Time
<0.001
AV-2-73 Concentration (= High)
0,38
Gender (=Male)
0,535
APOE4 status (=True)
0,643
Age (=Low)
0,946
Donepezil treatment (=True)
0,959

Time : AV2-73 Concentration (=High)
<0.0001
Time : APOE4 status (=True)
<0.0001
AV2-73 Concentration (=High) : APOE4 status (=True)
0,762
Baseline MMSE (=Low)
0,315
SIGMAR1 Q2P variant (=True)
0,704
COMT variant (=True)
0,523
SIGMAR1 variant Q2P (=True) : Time
<0.01
COMT variant (=True) : Time
<0.01
SIGMAR1 Q2P variant (=True) : AV2-73 Concentration (=High)
0,716
LME model output for Change in ADCS-ADL outcome

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News